Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Melanoma HELP
Based on 34,116 articles published since 2008
|||| 19 

These are the 34116 published articles about Melanoma that originated from Worldwide during 2008-2019.
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
226 Editorial Failure of fidelity of vertical transmission of epigenetic patterning as the basis of cancer. 2014

Riley, Patrick A. ·Totteridge Institute for Advanced Studies, London N20 8AB, UK. ·Melanoma Res · Pubmed #25185692.

ABSTRACT: -- No abstract --

227 Editorial MAP-kinase pathway up or down? Just look at the skin of your patients! 2014

Robert, Caroline / Thomas, Marina / Mateus, Christina. ·aDermatology Service, Gustave Roussy bINSERM U981, Paris Sud University, Villejuif, France. ·Melanoma Res · Pubmed #25185691.

ABSTRACT: -- No abstract --

228 Editorial The world of pigment cell research. 2014

Bosenberg, Marcus / Arnheiter, Heinz / Kelsh, Robert. · ·Pigment Cell Melanoma Res · Pubmed #25175381.

ABSTRACT: -- No abstract --

229 Editorial False-negative sentinel lymph node biopsy in melanoma patients. 2014

Manca, Gianpiero / Rubello, Domenico / Romanini, Antonella / Mariani, Giuliano. ·aRegional Center of Nuclear Medicine, University of Pisa bDepartment of Oncology, University Hospital of Pisa, Pisa cDepartment of Nuclear Medicine, 'Santa Maria della Misericordia' Hospital, Rovigo, Italy. ·Nucl Med Commun · Pubmed #25148652.

ABSTRACT: -- No abstract --

230 Editorial The clinical presentation of the high-mitotic-rate melanoma. 2014

Balin, Samuel J / Barnhill, Raymond L. ·David Geffen School of Medicine at University of California, Los Angeles. · Division of Dermatopathology, Department of Pathology and Laboratory Medicine, University of California, Los Angeles Medical Center, Los Angeles. ·JAMA Dermatol · Pubmed #25142555.

ABSTRACT: -- No abstract --

231 Editorial [Lentigo maligna: a diagnostic and therapeutic challenge]. 2014

Alcalay, Joseph. · ·Harefuah · Pubmed #25112116.

ABSTRACT: Lentigo maligna is an early type of melanoma which appears in sun damaged skin. The clinical diagnosis as well as the pathological diagnosis are a challenge to the clinician and the pathologist since atypical proliferation of melanocytes is a common finding in chronically sun exposed skin. The use of a dermatoscope and in vivo reflectance confocal microscopy as diagnostics aids can make the clinical diagnosis more accurate. Mohs micrographic surgery has become the standard of care, if available, for lentigo maligna.

232 Editorial Skin cancer: prevention is better than cure. 2014

Anonymous7590802. · ·Lancet · Pubmed #25110266.

ABSTRACT: -- No abstract --

233 Editorial Sentinel lymph node biopsy for melanoma: a plea to let the data be heard. 2014

Thompson, John F / Faries, Mark B / Cochran, Alistair J. ·Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia, john.thompson@melanoma.org.au. ·Ann Surg Oncol · Pubmed #25103536.

ABSTRACT: -- No abstract --

234 Editorial [Sentinel biopsy, a short outline-editorial]. 2014

Fait, Vuk. · ·Vnitr Lek · Pubmed #25069143.

ABSTRACT: -- No abstract --

235 Editorial Sentinel lymph node biopsy for melanoma: a plea to let the data speak. 2014

Coit, Daniel. ·Memorial Sloan-Kettering Cancer Center, New York, NY, USA, coitd@mskcc.org. ·Ann Surg Oncol · Pubmed #25059791.

ABSTRACT: -- No abstract --

236 Editorial Melanoma: the role of surgery in the era of new therapies. 2014

Mozzillo, Nicola / Ascierto, Paolo A. ·Department of Melanoma and Soft Tissue, Istituto Nazionale Tumori Fondazione "G, Pascale", Via Mariano Semmola, 80131 Naples, Italy. paolo.ascierto@gmail.com. ·J Transl Med · Pubmed #25015684.

ABSTRACT: -- No abstract --

237 Editorial Sentinel node followed by completion lymph node dissection versus nodal observation: staging or therapeutic? Controversy continues despite final results of MSLT-1. 2014

van Akkooi, Alexander C J. ·Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. ·Melanoma Res · Pubmed #24992628.

ABSTRACT: -- No abstract --

238 Editorial Demonstrating the benefits of clinical nuclear imaging: is it time to add economic analysis? 2014

Høilund-Carlsen, Poul F / Gerke, Oke / Vach, Werner. ·Department of Nuclear Medicine, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense C, Denmark, pfhc@rsyd.dk. ·Eur J Nucl Med Mol Imaging · Pubmed #24986737.

ABSTRACT: -- No abstract --

239 Editorial [Melanoma early detection and automatic diagnosis of pigmented lesions]. 2014

Stolz, Wilhelm. · ·J Dtsch Dermatol Ges · Pubmed #24981466.

ABSTRACT: -- No abstract --

240 Editorial Melanoma surveillance in "high-risk" individuals. 2014

Halpern, Allan C / Marchetti, Michael A / Marghoob, Ashfaq A. ·Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York. ·JAMA Dermatol · Pubmed #24965763.

ABSTRACT: -- No abstract --

241 Editorial Mutations in oncogenes: context matters. 2014

Gilks, C Blake. ·Rm 1259, 1st Floor JPPN, Dept of Pathology, Vancouver General Hospital, 910 W 10th Ave., Vancouver, BC V5Z 4E3, Canada. Electronic address: Blake.Gilks@vch.ca. ·Gynecol Oncol · Pubmed #24952407.

ABSTRACT: -- No abstract --

242 Editorial How detection of epigenetic alterations of blood-borne DNA could improve melanoma diagnosis. 2014

Hatzimichael, Eleftheria / Syed, Nel / Lo Nigro, Cristiana / Rao, Bhavya / Crook, Tim. ·Interscience Molecular Oncology Laboratory, University of Ioannina Cancer Biobank Center, Ioannina, Greece. ·Expert Rev Mol Diagn · Pubmed #24926921.

ABSTRACT: Detection in blood of the genetic and epigenetic changes present in metastatic cancers is opening up new possibilities in molecular diagnostics. A number of methodological and clinical issues await resolution before serum epigenetic biomarkers can be considered a routine part of the management of melanoma patients following primary excision. However, there is every possibility that blood testing for the presence of methylated DNA will become an integral part of the clinical follow-up of such patients. The ability to identify patients with subclinical (asymptomatic) metastatic melanoma, combined with new, highly active targeted and immunomodulatory agents, may lead to further improvements in outcomes for this patient population.

243 Editorial Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment. 2014

Camisaschi, Chiara / Vallacchi, Viviana / Castelli, Chiara / Rivoltini, Licia / Rodolfo, Monica. ·Unit of Immunotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. ·Expert Rev Mol Diagn · Pubmed #24914691.

ABSTRACT: Melanoma is an immunogenic tumor and immunotherapy treatment has established an increase in disease-free and overall survival in melanoma patients. However, a complex network of immunosuppressive mechanisms has been demonstrated to occur at the tumor site and in locoregional immune districts, such as sentinel lymph nodes (SLNs). The interplay between tumor cells and the local microenvironment leads to a tumor-driven shaping of the immune response that results in a heterogeneous cellular and molecular composition of tumor infiltrating lymphocytes (TILs). Several studies have reported the potential prognostic value of TILs infiltrating primary tumors and the association of 'immune signature' in SLNs and in melanoma metastases with prognosis and responsiveness to immunotherapeutic approaches. However, a systematic and deeper characterization of the local immunological status of TILs and SLNs is still required to refine melanoma stage classification.

244 Editorial Sleep apnoea and cancer: the new challenge. 2014

Lévy, Patrick / Godin-Ribuot, Diane / Pepin, Jean-Louis. ·Univ Grenoble Alpes, HP2 Laboratory, Grenoble, France INSERM, HP2 Laboratory U1042, Grenoble, France University Hospital, CHU Grenoble, Physiology Department, Grenoble, France PLevy@chu-grenoble.fr. · Univ Grenoble Alpes, HP2 Laboratory, Grenoble, France INSERM, HP2 Laboratory U1042, Grenoble, France. · Univ Grenoble Alpes, HP2 Laboratory, Grenoble, France INSERM, HP2 Laboratory U1042, Grenoble, France University Hospital, CHU Grenoble, Physiology Department, Grenoble, France. ·Eur Respir J · Pubmed #24881059.

ABSTRACT: -- No abstract --

245 Editorial Increased clarity on the use of radiotherapy in the management of desmoplastic melanoma. 2014

Tishler, Roy B. · ·Cancer · Pubmed #24877163.

ABSTRACT: -- No abstract --

246 Editorial Agents make "preferred list" in metastatic melanoma. 2014

Thompson, John A. ·Presented by John A. Thompson, MD, Co-Director, Melanoma Clinic, Seattle Cancer Care Alliance, Seattle, Washington. ·J Natl Compr Canc Netw · Pubmed #24853217.

ABSTRACT: The 2014 version of the NCCN Guidelines for Melanoma lists 6 preferred regimens, most with a category 1 recommendation, and 8 "other active regimens." Effective new agents include ipilimumab, a monoclonal anti-CTLA4 antibody, and agents targeted against mutated BRAF and MEK. Researchers are now focused on the optimal way to combine or sequence these agents, while exploring other new classes.

247 Editorial Heads up for scalp melanoma. 2014

Sarnoff, Deborah S. · ·J Drugs Dermatol · Pubmed #24809872.

ABSTRACT: -- No abstract --

248 Editorial Breakthrough therapies in melanoma. 2014

Lianos, Georgios D / Mangano, Alberto / Rausei, Stefano / Roukos, Dimitrios H. ·Centre for Biosystems & Genomic Network Medicine, University of Ioannina, Ioannina, GR 451 10, Greece. ·Future Oncol · Pubmed #24799059.

ABSTRACT: -- No abstract --

249 Editorial Investigating the metastatic niche in melanoma: a new therapeutic opportunity? 2014

Aladowicz, Ewa / Lanfrancone, Luisa. ·Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology & Cancer Therapeutics, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK. ·Future Oncol · Pubmed #24799050.

ABSTRACT: -- No abstract --

250 Editorial Counterphobia and poor sun protection practices in first-degree relatives of melanoma patients. 2014

Klimas, Natasha K / Turrentine, Jake E / Cayce, Rachael L. ·University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA. rachael.cayce@utsouthwestern.edu. ·Cutis · Pubmed #24738091.

ABSTRACT: -- No abstract --

Back · Next